Deoxyribonucleoside treatment rescues EtBr ‐induced mtDNA depletion in iPSC ‐derived neural stem cells with POLG mutations
Open Access
- 16 August 2023
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 37 (9) , e23139
Abstract
Mutations in POLG , the gene encoding the catalytic subunit of the mitochondrial DNA (mtDNA) polymerase gamma (Pol‐γ), lead to diseases driven by defective mtDNA maintenance. Despite being the most prevalent cause of mitochondrial disease, treatments for POLG‐related disorders remain elusive. In this study, we used POLG patient‐induced pluripotent stem cell (iPSC)‐derived neural stem cells (iNSCs), one homozygous for the POLG mutation c.2243G>C and one compound heterozygous with c.2243G>C and c.1399G>A, and treated these iNSCs with ethidium bromide (EtBr) to study the rate of depletion and repopulation of mtDNA. In addition, we investigated the effect of deoxyribonucleoside (dNs) supplementation on mtDNA maintenance during EtBr treatment and post‐treatment repopulation in the same cells. EtBr‐induced mtDNA depletion occurred at a similar rate in both patient and control iNSCs, however, restoration of mtDNA levels was significantly delayed in iNSCs carrying the compound heterozygous POLG mutations. In contrast, iNSC with the homozygous POLG mutation recovered their mtDNA at a rate similar to controls. When we treated cells with dNs, we found that this reduced EtBr‐induced mtDNA depletion and significantly increased repopulation rates in both patient iNSCs. These observations are consistent with the hypothesis that mutations in POLG impair mtDNA repopulation also within intact neural lineage cells and suggest that those with compound heterozygous mutation have a more severe defect of mtDNA synthesis. Our findings further highlight the potential for dNs to improve mtDNA replication in the presence of POLG mutations, suggesting that this may offer a new therapeutic modality for mitochondrial diseases caused by disturbed mtDNA homeostasis.Keywords
Funding Information
- L. Meltzers Høyskolefond (103517133)
- Norges Forskningsråd (229652, 262613)
This publication has 38 references indexed in Scilit:
- Defects in mitochondrial DNA replication and human diseaseCritical Reviews in Biochemistry and Molecular Biology, 2011
- A Review Comparing Deoxyribonucleoside Triphosphate (dNTP) Concentrations in the Mitochondrial and Cytoplasmic Compartments of Normal and Transformed CellsNucleosides, Nucleotides & Nucleic Acids, 2011
- Limited dCTP Availability Accounts for Mitochondrial DNA Depletion in Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE)PLOS Genetics, 2011
- POLG mutations cause decreased mitochondrial DNA repopulation rates following induced depletion in human fibroblastsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Mitochondrial DNA repair in aging and diseaseMechanisms of Ageing and Development, 2008
- Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variantsNature Genetics, 2006
- The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 casesBrain, 2006
- Mitochondrial DNA Polymerase W748S Mutation: A Common Cause of Autosomal Recessive Ataxia with Ancient European OriginThe American Journal of Human Genetics, 2005
- In situ localization of mitochondrial DNA replication in intact mammalian cells.Journal of Cell Biology, 1996
- THE EFFECT OF ETHIDIUM BROMIDE ON MITOCHONDRIAL DNA SYNTHESIS AND MITOCHONDRIAL DNA STRUCTURE IN HELA CELLSJournal of Cell Biology, 1971